Exelixis
EXEL
#1350
Rank
โ‚น1.503 T
Marketcap
โ‚น6,163
Share price
-3.25%
Change (1 day)
63.17%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

Stock price history for Exelixis (EXEL)

Highest end of day price: โ‚น6,786 INR on 2026-11-04

Lowest end of day price: โ‚น120.33 INR on 2014-12-24

Stock price history of Exelixis from 2000 to 2026

Annual Stock Price Performance

Year Performance
2026 55.81%
2025 29.14%
2024 39.16%
2023 47.18%
2022-16.37%
2021-10.96%
2020 13.65%
2019-11.59%
2018-37.36%
2017 106.38%
2016 171.58%
2015 241.82%
2014-76.70%
2013 26.92%
2012-1.93%
2011-44.24%
2010 9.47%
2009 41.19%
2008-42.56%
2007-8.87%
2006-7.60%
2005 2.39%
2004 35.71%
2003-7.24%
2002-49.40%
2001 31.00%
2000-0.85%

Stock price for similar companies or competitors

Company Stock price Change 1d% Country
โ‚น24,861-2.27%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น2,576-1.57%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น41,059-0.84%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น4,289-2.41%๐Ÿ‡ซ๐Ÿ‡ท France
โ‚น12,386-3.63%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น5,462-1.68%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น4,474-1.28%๐Ÿ‡ฌ๐Ÿ‡ง UK
โ‚น48.22-16.04%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น1,399 0.00%๐Ÿ‡บ๐Ÿ‡ธ USA